Advanced Research in Neuroprotection

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".

Deadline for manuscript submissions: 30 November 2024 | Viewed by 44

Special Issue Editors


E-Mail Website
Guest Editor
2nd Neurological University Department, Aristotle University of Thessaloniki, AHEPA General Hospital, 54634 Thessaloniki, Greece
Interests: neuroimmunology; experimental neurology; neurodegenerative diseases

E-Mail Website
Guest Editor
2nd Neurological University Department, Aristotle University of Thessaloniki, AHEPA General Hospital, 54634 Thessaloniki, Greece
Interests: neuroimmunology; experimental neurology; neurodegenerative diseases; neuropathology

Special Issue Information

Dear Colleagues,

Despite their privileged nature, the central and peripheral nervous systems may suffer injury and are vulnerable to immune attacks. Neuroinflammatory manifestations accompany alterations to the microenvironment, which may lead to neuronal dysregulation and the appearance of neurological disorders. Despite the distinct entity of each nervous system disease, they share common pathological traits, such as biochemical damage, oxidative stress, axonal loss, and neuronal death, thus revealing the essential role of neuroprotective pathways in ensuring neuronal homeostasis and longevity. Breakthroughs in the field of drug desig and neuropharmacology along with the latest progress in animal and human models have shown the utility of translational medicine, advocating for more appropriate strategies and pharmacologic agents that can mediate the task of neuroprotection.

This Special Issue, entitled “Advanced Research in Neuroprotection”, invites original research articles, short reports, and reviews that will expertly present recent advances in both experimental and clinical knowledge of neuroprotective mechanisms and strategies within various neurological disorders.

Dr. Evangelia Kesidou
Dr. Iliana Michailidou
Dr. Christos Bakirtzis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neuroprotection
  • neurodegeneration
  • neuroinflammation
  • axonal loss
  • neuropharmacology
  • traumatic brain injury
  • blood–brain barrier

Published Papers

This special issue is now open for submission.
Back to TopTop